RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mezzion Pharma Co Stock

Mezzion Pharma Co Equity 2024

Mezzion Pharma Co Equity

61.44 B KRW

Ticker

140410.KQ

ISIN

KR7140410002

In 2024, Mezzion Pharma Co's equity was 61.44 B KRW, a 134.16% increase from the 26.24 B KRW equity in the previous year.

Mezzion Pharma Co Aktienanalyse

What does Mezzion Pharma Co do?

Mezzion Pharma Co Ltd is a biopharmaceutical company based in South Korea, focused on the development and commercialization of therapeutics for the treatment of heart diseases. The company was founded in 2009 and has been listed on the Korea Stock Exchange since 2014. Mezzion Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Mezzion Pharma Co's Equity

Mezzion Pharma Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Mezzion Pharma Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Mezzion Pharma Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Mezzion Pharma Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Mezzion Pharma Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Mezzion Pharma Co stock

What is the equity of Mezzion Pharma Co this year?

Mezzion Pharma Co has equity of 61.44 B KRW this year.

What was the equity of Mezzion Pharma Co compared to the previous year?

The equity of Mezzion Pharma Co has increased/decreased by 134.16% increased compared to the previous year.

What impact does a high equity have on investors of Mezzion Pharma Co?

A high equity is advantageous for investors of Mezzion Pharma Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Mezzion Pharma Co?

A low equity can be a risk for investors of Mezzion Pharma Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Mezzion Pharma Co affect the company?

An increase in equity of Mezzion Pharma Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Mezzion Pharma Co affect the company?

A reduction in equity of Mezzion Pharma Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Mezzion Pharma Co?

Some factors that can affect the equity of Mezzion Pharma Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Mezzion Pharma Co so important for investors?

The equity of Mezzion Pharma Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Mezzion Pharma Co take to change the equity?

To change equity, Mezzion Pharma Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Mezzion Pharma Co pay?

Over the past 12 months, Mezzion Pharma Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mezzion Pharma Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Mezzion Pharma Co?

The current dividend yield of Mezzion Pharma Co is .

When does Mezzion Pharma Co pay dividends?

Mezzion Pharma Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mezzion Pharma Co?

Mezzion Pharma Co paid dividends every year for the past 0 years.

What is the dividend of Mezzion Pharma Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mezzion Pharma Co located?

Mezzion Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mezzion Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mezzion Pharma Co from 4/1/2013 amounting to 25 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2012.

When did Mezzion Pharma Co pay the last dividend?

The last dividend was paid out on 4/1/2013.

What was the dividend of Mezzion Pharma Co in the year 2023?

In the year 2023, Mezzion Pharma Co distributed 0 KRW as dividends.

In which currency does Mezzion Pharma Co pay out the dividend?

The dividends of Mezzion Pharma Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mezzion Pharma Co

Our stock analysis for Mezzion Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mezzion Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.